Rhythm

Coala Life and My Cardiologist to roll-out the largest Real-Time Cardiac Monitoring program in Florida

Remote Patient Monitoring (RPM) program enabling long-term and real-time cardiac monitoring of patients in the safety of their homes IRVINE, Calif., July 22, 2020 /PRNewswire/ — Coala Life, the award-winning Swedish innovator of real-time remote cardiac monitoring solutions and the Florida-based My Cardiologist group have partnered to roll-out the most comprehensive cardiac RPM […]

LifeSignals Wireless Medical Biosensor LP1250 receives FDA clearance

– World’s first single-use two channel ECG and heart rate biosensor provides 72-hour patient monitoring with remote data access in ambulatory, hospital and home settings FREMONT, Calif., July 21, 2020 /PRNewswire/ — LifeSignals Group, today announced USFDA 510(k) clearance has been received for their LifeSignals ECG Remote Monitoring Patch Platform. The LifeSignals […]

CVRx® Completes Enrollment of the BeAT-HF Phase III Randomized Clinical Trial, Continues to collect Morbidity and Mortality Outcomes

CVRx Enrolls the First Patient in a Post Market Heart Failure Registry MINNEAPOLIS, July 21, 2020 /PRNewswire/ — CVRx, Inc., a private medical device company, announced that the BeAT-HF phase III randomized clinical trial has completed enrollment in the post-market phase. CVRx has also enrolled the first patient in a heart failure (“HF”) […]

VectraCor and GS GmbH (Corpuls) Form Licensing Agreement to Incorporate VectraCor’s 22-Lead ECG and CEB® (Cardiac Electrical Biomarker) Technology in Corpuls Defibrillators

Both Companies Committed to Bringing the Best Cardiac Care to the Healthcare Workers and Patients that Need It TOTOWA, New Jersey, July 16, 2020 /PRNewswire/ — GS Elektromedizinische Geraete G. Stemple GmbH, marketing defibrillators under the corpuls brand, and VectraCor Inc., announced today that they have concluded a licensing agreement allowing corpuls to incorporate VectraCor’s […]

Cardiva Medical Announces First Patients Enrolled in The AMBULATE Same Day Discharge Study Using VASCADE® MVP

First Prospective Multi-Center Study Evaluating Same Day Discharge for Patients Undergoing Cardiac Ablation Procedures for Atrial Fibrillation SANTA CLARA, Calif., July 16, 2020 (GLOBE NEWSWIRE) — Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced the first patient enrollments in its AMBULATE Same Day Discharge study, […]

Vivasc Therapeutics Inc. Receives NIH Phase I STTR Grant to Utilize Novel Cardiac Targeting Peptides for Targeted Delivery of Amiodarone to the Heart for Treatment of Atrial Fibrillation

This approach may minimize systemic toxicity associated with amiodarone PITTSBURGH–(BUSINESS WIRE)–The University of Pittsburgh and Vivasc Therapeutics Inc. today announced a research grant awarded by the NIH National Heart, Lung, and Blood Institute, valued at approximately $327,000 for the continued development of CTP-amio, the company’s lead compound, for the treatment […]

Biotricity® Partners with Verizon to Develop EMS Solutions

Verizon to Integrate the Bioflux® Solution into their EMS and Launch to Existing and Future Customers REDWOOD CITY, Calif., July 14, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company announced a strategic partnership with Verizon (NYSE: VZ) to develop EMS solutions for First Responders by integrating […]

Benefits of Stereotaxis Robotic Technology in COVID-19 Patient Highlighted in Publication

ST. LOUIS, July 13, 2020 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication in the European Heart Journal highlighting the benefits of Stereotaxis’ robotic technology in a COVID-19 patient. The publication concludes that catheter ablation “should be […]

Quantum Genomics Enrolls First Patient in Its Pivotal Phase III FRESH Trial of Firibastat in Difficult-to-treat and Resistant Hypertension

PARIS and NEW YORK, July 13, 2020 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly targets the brain to treat difficult-to-treat and resistant hypertension and heart failure, today announced the enrollment of the first patient in the Company’s […]

HD Medical Awarded FDA Clearance For HD Steth

Intelligent Stethoscope with Integrated ECG delivers Instant Cardiac Insights SANTA CLARA, Calif.–(BUSINESS WIRE)–HD Medical, Inc. of Silicon Valley today announces that its flagship product, HD Steth, has received FDA clearance for all three product classification codes of DQD, DQC and DPS for Electronic Stethoscope, Phonocardiograph and Electrocardiograph combined into one device. HD Steth utilizes […]